Tag: Best Biochemistry Award

Magdalena Koziol | Biochemistry | Research Excellence Award

Published on by WSA Awards

Assist. Prof. Dr. Magdalena Koziol | Biochemistry | Research Excellence Award

Chinese Instistute for Brain Research | China

Dr. Magdalena Koziol is an Assistant Professor and Principal Investigator at the Chinese Institute for Brain Research (CIBR), China, where she leads an innovative research program at the intersection of developmental biology, epigenetics, and neuroscience. She completed her PhD in Developmental Biology at the University of Cambridge, UK, supported by a prestigious Wellcome Trust Studentship, with laboratory rotations under globally recognized leaders including Sir John B. Gurdon, Sarah Bray, and Azim Surani. Prior to this, she earned a BSc in Medical Genetics from the University of Leicester, UK, where she received two academic excellence awards, and previously undertook Physics studies at the University of Stuttgart, Germany. Dr. Koziol’s postdoctoral career includes highly competitive appointments with Sir John B. Gurdon at the Gurdon Institute, Antonio Giraldez at Yale University, and John Rinn at Harvard University and the Broad Institute. Her interdisciplinary background has helped shape a research portfolio focused on uncovering previously unknown chemical modifications of DNA and RNA and understanding their functional relevance in the vertebrate brain. Her groundbreaking discovery of methylated deoxyadenosine (m6dA) in vertebrate genomes, published in 2015, established a new field of study in epigenetic regulation and earned recognition from AAAS Science for excellence in scientific achievement. Her research has secured major competitive funding, including support from the Beijing Natural Science Foundation, the Koziol Laboratory core funding at CIBR, the BBSRC (UK), the Isaac Newton Trust, and the Human Frontiers Long-Term Fellowship program. She has also been recognized with distinguished honors, including an invitation to Buckingham Palace by Queen Elizabeth II. Through high-impact publications, international collaboration, and translational scientific vision, Dr. Koziol’s work contributes to advancing molecular neuroscience, with growing implications for understanding brain disorders and developing therapeutic strategies.

Profiles: ORCID

Featured Publications

Li, S., Zhang, S., Li, H., Yin, N., Yang, R., Zhang, Y., Koziol, M. J., & Faiola, F. (2025). Environmental UV filters threaten human neurodevelopment: Disruption of central and peripheral nervous system lineage commitment via WNT signaling dysregulation.

Feng, S., & Koziol, M. J. (2025). Unraveling brain complexity: From single-cell to spatial m6A technologies.

Feng, S., Tellaetxe-Abete, M., Zhang, Y., Peng, Y., Zhou, H., Dong, M., Larrea, E., Xue, L., Zhang, L., & Koziol, M. J. (2024). Single-cell discovery of m6A RNA modifications in the hippocampus.

Feng, S., Tellaetxe-Abete, M., Zhang, Y., Peng, Y., Zhou, H., Dong, M., Larrea, E., Xue, L., Zhang, L., & Koziol, M. J. (2023, December 13). Single-cell discovery of m6A RNA modifications in the hippocampus.

Wen, M.-H., Triana, H. B., Butler, R., Hu, H.-W., Dai, Y.-H., Lawrence, N., Hong, J.-J., Garrett, N., Jones-Green, R., Rawlins, E. L., & others. (2023). Deterministic nuclear reprogramming of mammalian nuclei to a totipotency-like state by amphibian meiotic oocytes for stem cell therapy in humans.

Georgia Zahariou | Biochemistry | Research Excellence Award

Published on by WSA Awards

Dr. Georgia Zahariou | Biochemistry | Research Excellence Award

Institute of Nanoscience and Nanotechnology, NCSR “Demokritos”, Athens, Greece

Dr. Georgia Zahariou is an accomplished physicist specializing in Electron Paramagnetic Resonance (EPR) spectroscopy, photosynthetic water oxidation mechanisms, and bioinorganic magnetic materials. She is currently a Postdoctoral Researcher at the Institute of Nanoscience and Nanotechnology at the National Center for Scientific Research (NCSR) Demokritos in Athens, Greece, where she contributes to cutting-edge research on photosystem II and the molecular mechanisms underlying oxygen evolution. Dr. Zahariou earned her Ph.D. in Physics from the National and Kapodistrian University of Athens in collaboration with NCSR Demokritos, graduating with Excellence. Her doctoral research focused on spin-spin interactions in metalloradical systems and the mechanistic study of natural photosynthetic water splitting, forming the foundation of her long-term scientific trajectory. She also holds a Master’s degree in Solid-State Physics and a Bachelor’s degree in Physics from the same institution. With extensive research experience across leading laboratories in Greece and internationally—including the University of Padova and the University of Crete—Dr. Zahariou has contributed to multiple national and European research programs such as HELIOS, THALIS, and KRIPIS. She has presented her work at numerous international conferences, delivered invited talks, and earned important distinctions including the Young Talent Award (2015) and the 4th Poster Prize (2007) from the International Society of Photosynthesis Research. Her scientific output includes over 25 peer-reviewed journal articles, book chapters, and conference proceedings, with contributions published in high-impact venues like Angewandte Chemie, FEBS Letters, and Biochemistry. Her research features both experimental and theoretical studies, reflecting strong interdisciplinary expertise in spectroscopy, magnetochemistry, molecular bioenergetics, and computational modeling. Dr. Zahariou’s work continues to advance global understanding of catalytic mechanisms in natural and artificial photosynthesis, positioning her as a recognized expert in magnetic resonance applications to biological energy conversion.

Profiles: Scopus | ORCID

Featured Publications

  1. (2021). Di-2-pyridyl ketone-based ligands as evergreen “trees” in the “forest” of manganese chemistry: Mononuclear Mn(III) complexes from the use of MnF₃. Polyhedron, 207, Article 115350.

  2. (2021). Arrested substrate binding resolves catalytic intermediates in higher-plant water oxidation. Angewandte Chemie International Edition, 60, 3156–3162.

  3. (2021). Electronic properties of the S = 5/2 Mn(II) complexes [MnPhC(O)NP(O)PPh₂(N,N)(NO₃)], (N,N) = phenanthroline, neocuproine, 2,2′-bipyridine. Polyhedron, 207, Article 115374.

  4. (2021). Electronic structure of tyrosyl D radical of photosystem II, as revealed by 2D-hyperfine sublevel correlation spectroscopy. Magnetochemistry, 7, Article 131.

  5. (2021). Orientational Jahn–Teller isomerism in the dark-stable state of nature’s water oxidase. Angewandte Chemie International Edition, 60, 13493–13499.

Neng Jiang | Biochemistry | Best Researcher Award

Published on by WSA Awards

Dr. Neng Jiang | Biochemistry | Best Researcher Award

Sun Yat-sen University Cancer Center | China

Dr. Neng Jiang is a highly accomplished pathologist and cancer researcher, recognized for his expertise in angiogenesis and stem cell biology within the context of lung cancer. With both an MD and a Ph.D., he has established himself as a leading academic and clinical researcher at the Department of Pathology, Sun Yat-sen University Cancer Center in Guangzhou, China, one of Asia’s foremost institutions for oncology research. His career is defined by a commitment to advancing diagnostic pathology and deepening the understanding of cancer mechanisms, with a focus on bridging molecular discoveries with real-world clinical applications. Over the years, Dr. Jiang has authored multiple publications in high-impact international journals indexed in Scopus, PubMed, and Web of Science, contributing valuable knowledge to the global medical community. His ability to integrate clinical observations with experimental research has positioned him as a crucial contributor to translational oncology, enabling better strategies for early detection and targeted therapies. Through international collaborations and active engagement in academic forums, he has established a strong global presence. With a career dedicated to advancing cancer research and improving patient outcomes, Dr. Jiang exemplifies the role of a researcher whose work drives innovation, education, and clinical transformation in modern oncology.

Professional Profile

Education

Dr. Neng Jiang’s academic foundation is firmly rooted in medicine and research, reflecting his dual training as a clinician and scientist. He pursued his Doctor of Medicine (MD) with a specialization in pathology, equipping him with extensive knowledge of human disease processes and diagnostic methodologies. Following his medical degree, he undertook a Doctor of Philosophy (Ph.D.) in Oncology and Pathology, which allowed him to explore advanced mechanisms of cancer development, particularly angiogenesis and cancer stem cell biology. His Ph.D. research, conducted at Sun Yat-sen University Cancer Center, emphasized the tumor microenvironment and molecular factors influencing cancer progression, with findings that contributed to the academic literature in the field. Throughout his education, Dr. Jiang actively engaged in research activities, conference presentations, and collaborative projects, which strengthened both his theoretical and practical understanding of oncology. His commitment to academic excellence is reflected in his strong track record of publications during his doctoral studies. By combining clinical medical training with rigorous scientific inquiry, Dr. Jiang’s education uniquely prepared him to bridge the gap between laboratory research and patient care, laying the foundation for his impactful career in pathology and oncology research at national and international levels.

Professional Experience

Dr. Neng Jiang’s professional career has been characterized by his contributions to both clinical pathology and academic research. He currently serves at the Department of Pathology, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, one of the most prestigious oncology research institutions in China. In this role, he has been deeply involved in diagnostic pathology while leading projects that investigate the biological basis of cancer progression. His experience extends across collaborative clinical studies, translational research, and guiding younger researchers in pathology-related investigations. Dr. Jiang has worked extensively with multidisciplinary teams, both domestically and internationally, enabling him to contribute to projects that integrate clinical practice with laboratory innovation. His professional portfolio includes participation in major research initiatives aimed at improving cancer diagnostics, treatment strategies, and biomarker discovery. He has also presented his work at leading scientific conferences, where he has shared critical insights with the global pathology and oncology community. Beyond his research and clinical commitments, Dr. Jiang plays a role in academic mentorship, training medical students and junior researchers, thereby fostering the next generation of cancer scientists. His professional journey highlights a balance of leadership, innovation, and dedication to advancing oncology.

Research Interests

Dr. Neng Jiang’s primary research interests lie at the intersection of angiogenesis, stem cell biology, and lung cancer pathology, areas that are central to understanding tumor initiation, growth, and metastasis. He has a particular focus on the molecular pathways and tumor microenvironmental factors that drive cancer progression, with the ultimate aim of developing more effective therapeutic interventions. His work explores how abnormal vascular growth supports cancer survival and how cancer stem cells contribute to resistance to therapy and recurrence. In addition to lung cancer, he has engaged in research that evaluates biomarkers for cancer diagnosis and prognosis, contributing to precision medicine approaches in oncology. Dr. Jiang’s research interests also include translational applications, where discoveries in the laboratory are applied to clinical settings, bridging the gap between basic science and patient care. By combining pathology expertise with molecular research, he aims to identify novel targets for anti-cancer therapies and improve strategies for early cancer detection. His dedication to these research areas is evident in his growing body of publications in high-impact journals and his collaborations with international experts. This focus ensures that his work continues to make meaningful contributions to both academic research and clinical oncology practice.

Research Skills

Over the course of his academic and professional career, Dr. Neng Jiang has developed an extensive range of research skills that make him highly effective in cancer pathology and translational oncology. His expertise spans both laboratory-based and clinical methodologies. He is proficient in histopathology, immunohistochemistry, molecular diagnostics, and biomarker analysis, enabling him to provide detailed insights into tumor biology. Dr. Jiang has also mastered experimental techniques related to cell culture, angiogenesis assays, and stem cell studies, which are vital for investigating mechanisms of tumor growth and resistance. Beyond laboratory skills, he has strong experience in scientific writing, data interpretation, and statistical analysis, ensuring his research is rigorous and impactful. His ability to integrate clinical observations with molecular-level data distinguishes his work and allows him to develop comprehensive approaches to cancer research. Additionally, Dr. Jiang is adept at working in multidisciplinary research environments, coordinating with oncologists, molecular biologists, and clinicians to achieve common goals. He also has experience with international research platforms, presenting findings at conferences and contributing to global scientific dialogues. These skills, combined with his clinical training, position him as a well-rounded researcher capable of delivering impactful contributions to modern oncology.

Awards and Honors

Throughout his career, Dr. Neng Jiang has received recognition for his outstanding contributions to pathology and oncology research. His awards reflect both academic excellence and research innovation. He has been acknowledged for his impactful publications in high-impact journals, many of which focus on lung cancer pathology, angiogenesis, and stem cell biology. His work has contributed to the development of novel diagnostic and therapeutic approaches, earning him recognition at both national and international scientific forums. Dr. Jiang has also been invited to present his findings at leading conferences, where his presentations have received commendation for advancing the field of oncology. In addition to publication-related achievements, he has been honored with institutional awards from Sun Yat-sen University Cancer Center, recognizing his leadership and research excellence. His active participation in academic committees and professional societies has further solidified his standing as a respected member of the scientific community. While his career continues to evolve, the honors he has already received demonstrate his capacity for innovation, his dedication to patient-centered research, and his role as a thought leader in cancer pathology. These recognitions highlight his potential for future breakthroughs and leadership in global oncology research.

Publication Top Note

  • Defining homologous recombination deficiency status in pancreatic ductal adenocarcinoma: Clinical implications for evaluating response to platinum chemotherapy — 2025

Conclusion

In conclusion, Dr. Neng Jiang is a distinguished pathologist and oncology researcher whose career reflects a remarkable blend of academic excellence, clinical expertise, and research innovation. With his dual qualifications of MD and Ph.D., he has developed an in-depth understanding of cancer biology, particularly focusing on angiogenesis and stem cell pathways in lung cancer. His research contributions, published in reputed journals and presented at international conferences, have advanced knowledge in cancer pathology and created new avenues for therapeutic strategies. Professionally, he has played a critical role at the Sun Yat-sen University Cancer Center, where he combines clinical diagnostics with pioneering research initiatives. His skills in molecular diagnostics, translational research, and scientific leadership make him a valuable contributor to both academia and clinical oncology. Recognized with multiple awards and honors, Dr. Jiang’s career demonstrates consistent excellence and a commitment to improving patient outcomes. Looking forward, his ongoing dedication to research and collaboration promises further advancements in cancer detection and treatment. These qualities make him a deserving candidate for international recognition, particularly the Best Researcher Award, as he continues to shape the future of pathology and oncology at both national and global levels.

Aurora Daniele | Biochemistry | Best Researcher Award

Published on by WSA Awards

Prof. Dr. Aurora Daniele | Biochemistry | Best Researcher Award

University of Naples Federico II | Italy

Prof. Dr. Aurora Daniele is an accomplished academic and researcher with more than three decades of contributions to the fields of molecular biology, genetics, and biochemistry. Currently serving as a Full Professor at the Università degli Studi di Napoli “Federico II,” she has established herself as an influential figure in biomedical sciences with a broad focus ranging from enzymatic pathways and protein biosynthesis to lysosomal storage disorders and molecular diagnostics. Her career reflects a remarkable blend of academic leadership, impactful research, and international collaboration. Prof. Daniele has published extensively in top-tier journals, authoring over 136 scientific papers indexed in Scopus, Web of Science, and PubMed. With an h-index of 30 and more than 2,700 citations, her research is widely recognized and cited globally. She has collaborated with institutions such as the Mayo Clinic in the United States and played a pivotal role as Principal Investigator at CEINGE – Biotecnologie Avanzate. Beyond research, she has contributed to academic governance, serving as President of the School of Food and Nutrition Sciences at the University of Campania “L. Vanvitelli.” Through her outstanding work, Prof. Daniele has significantly advanced knowledge in life sciences while shaping the next generation of scholars and practitioners.

Professinal Profile

Scopus | ORCID

Education

Prof. Dr. Aurora Daniele’s academic journey began with a strong foundation in the life sciences. She pursued her degree in Biological Sciences at the Università degli Studi di Napoli “Federico II,” where she developed a keen interest in molecular biology, genetics, and biochemical research. Her rigorous training at this historic university provided her with both theoretical depth and practical expertise, enabling her to engage in cutting-edge research from the early stages of her career. Following her initial studies, she sought advanced scientific exposure through national and international fellowships, most notably at the Telethon Institute of Genetics and Medicine in Milan, Italy. During this formative period, she focused on molecular diagnostics, genetic regulation, and the study of metabolic pathways. These opportunities enriched her scientific outlook, broadening her expertise in clinical molecular biology and the application of advanced biotechnological methods. Her educational background, deeply rooted in one of Italy’s oldest and most prestigious institutions, provided the strong academic and research orientation that continues to guide her career today. This blend of local academic grounding and global research training has allowed Prof. Daniele to establish herself as a thought leader in genetics and molecular diagnostics.

Professional Experience

Prof. Dr. Aurora Daniele has an extensive record of academic leadership and professional achievements. She currently serves as Full Professor at the Università degli Studi di Napoli “Federico II,” where she has taught and mentored undergraduate, graduate, and doctoral students in life sciences, biochemistry, and genetics. Her professional trajectory includes notable leadership roles, such as her tenure as President of the School of Food and Nutrition Sciences at the University of Campania “L. Vanvitelli”. In addition, she has contributed significantly to clinical and translational research as Principal Investigator at CEINGE – Biotecnologie Avanzate, an advanced biotechnology research center in Naples. Her professional career has been marked by consistent efforts to integrate molecular diagnostics into clinical applications, advancing both science and healthcare. Prof. Daniele has also played an essential role in fostering collaborations with international institutions, including the Mayo Clinic in the United States, thereby broadening the impact of her research beyond Italy. As an educator and scientist, she has successfully combined laboratory innovation with academic leadership, resulting in a career that influences policy, teaching, and medical practice. Her professional achievements highlight her as a leader in Italian and international biomedical research.

Research Interests

Prof. Dr. Aurora Daniele’s research interests lie at the intersection of molecular biology, genetics, and clinical biochemistry. Her work primarily focuses on enzymatic pathways, protein biosynthesis, and the molecular mechanisms underlying lysosomal storage disorders. She has dedicated significant research efforts to understanding genetic regulation and transcriptomic responses, with particular attention to the signaling pathways involved in metabolic and degenerative diseases. Another central aspect of her research is the development and application of molecular diagnostic tools aimed at identifying genetic disorders and optimizing clinical interventions. She is equally interested in transcriptomic and proteomic studies, which provide a broader systems-level understanding of disease pathophysiology. Over the years, Prof. Daniele has expanded her research to include clinical molecular diagnostics, with an emphasis on bridging laboratory science and patient care. She has also contributed to the study of nutritional sciences, linking metabolism to molecular pathways, thereby highlighting the interplay between diet, genetics, and health outcomes. Her wide-ranging interests have allowed her to contribute meaningfully to both fundamental science and applied medicine, positioning her as a key figure in advancing knowledge in biomedicine, diagnostics, and personalized healthcare.

Research Skills

Prof. Dr. Aurora Daniele possesses a highly diverse and advanced skill set in molecular biology, biochemistry, and genetics. She is proficient in enzymatic assays, protein expression and purification techniques, and the analysis of signaling pathways critical to cellular function. Her expertise extends to transcriptomic and proteomic technologies, enabling her to study gene expression regulation and protein interactions at a systems biology level. Additionally, she has advanced skills in clinical molecular diagnostics, which she has applied in both laboratory and translational settings to improve the detection and understanding of genetic disorders. Prof. Daniele is skilled in molecular cloning, PCR, electrophoresis, and biochemical analysis of cellular mechanisms. Her research also demonstrates proficiency in developing and validating biomarkers for disease, particularly in lysosomal storage disorders. Beyond laboratory methods, she is adept at scientific writing, project leadership, and cross-disciplinary collaboration, often integrating expertise from different research domains. Her ability to combine technical precision with conceptual innovation has made her a valuable contributor to both basic and applied research. These skills, acquired over decades of work, form the backbone of her impactful contributions to modern biomedical sciences.

Awards and Honors

Throughout her career, Prof. Dr. Aurora Daniele has received recognition for her exceptional contributions to biomedical research and academic leadership. She has been consistently acknowledged for her role in advancing molecular biology and clinical biochemistry, as well as for her leadership positions within prestigious Italian universities. Serving as President of the School of Food and Nutrition Sciences at the University of Campania “L. Vanvitelli” reflects her academic excellence and administrative capabilities. Her extensive publication record, with over 136 papers indexed in Scopus, PubMed, and Web of Science, further testifies to her global recognition. With an h-index of 30 and over 2,700 citations, her influence within the scientific community is substantial. Beyond metrics, she has been invited to collaborate with international research institutions, including the Mayo Clinic, underscoring the value of her expertise in global biomedical research. While specific awards and formal honors add to her distinction, her career itself stands as a testament to sustained excellence, mentorship, and leadership. Her recognition is rooted not only in academic circles but also in her meaningful impact on advancing diagnostics, therapeutic strategies, and higher education.

Publication Top Notes

  • Exploring the role of serum adiponectin and its holigomerization in fibrotic interstitial lung diseases: results from a cross-sectional study — 2025

  • β-Hydroxybutyrate mitigates the detrimental effects of high glucose in human retinal pigment epithelial ARPE-19 cells — 2025

  • Adiponectin and HMW Oligomers in Relation to Inflammatory Markers in Crohn’s Disease Patients — 2025

  • Plasma adiponectin levels are associated with habitual dietary polyphenol intake in individuals at high cardiometabolic risk: a cross-sectional study — 2025

  • Exploring the Link Between Psoriasis and Adipose Tissue: One Amplifies the Other — 2024 — 2 citations

  • Impact of Lifestyle Interventions on Multiple Sclerosis: Focus on Adipose Tissue — 2024 — 3 citations

  • Effects of Exhaustive Exercise on Adiponectin and High-Molecular-Weight Oligomer Levels in Male Amateur Athletes — 2024 — 1 citation

  • LncRNA microarray profiling identifies novel circulating lncRNAs in hidradenitis suppurativa — 2024 — 3 citations

Conclusion

Prof. Dr. Aurora Daniele exemplifies the qualities of an outstanding researcher, educator, and leader in the fields of molecular biology, genetics, and biochemistry. With a career spanning more than three decades, she has consistently contributed to advancing both fundamental science and applied clinical practices. Her extensive research output, collaborations with international institutions, and leadership roles within Italian academia reflect her ability to integrate innovation, mentorship, and governance. She has effectively bridged laboratory research with healthcare applications, particularly in molecular diagnostics and metabolic disorders, thereby enhancing both scientific understanding and patient outcomes. Her skills, ranging from enzymatic assays to proteomic studies, highlight her versatility and technical excellence, while her publication record demonstrates her influence and recognition within the global scientific community. Prof. Daniele’s dedication to education has further amplified her impact, preparing the next generation of scientists and healthcare professionals. Her professional journey underscores a balance of academic rigor, international collaboration, and scientific creativity, making her a true leader in biomedical sciences. With her ongoing research and visionary outlook, she continues to shape the future of diagnostics, molecular medicine, and higher education, deserving recognition at the highest levels.

Mohammad Sadegh Hashemzadeh | Biochemistry |Best Researcher Award

Published on by WSA Awards

Assist Prof Dr. Mohammad Sadegh Hashemzadeh | Biochemistry |Best Researcher Award

Assist. Professor at Nanobiotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

Dr. Mohammad Sadegh Hashemzadeh is an accomplished Assistant Professor at Baqiyatallah University of Medical Sciences, specializing in Medical and Nano Biotechnology. He holds a Ph.D. in Nano Biotechnology, with a focus on recombinant protein production for therapeutic applications, including cell therapy for rheumatoid arthritis. Dr. Hashemzadeh has received numerous accolades, including top ranks in his B.Sc., M.Sc., and Ph.D. studies, and has published extensively in reputable journals on topics such as nanotechnology, viral protein production, and cancer treatment. His research expertise spans molecular genetics, genetic engineering, and the development of novel diagnostic methods for biological threats. Dr. Hashemzadeh’s contributions to the field are recognized internationally, making him a prominent figure in biotechnology research, particularly in Iran. His work bridges the gap between cutting-edge biotechnology and practical medical applications, reflecting his dedication to advancing health sciences.

Profile

Education

Dr. Mohammad Sadegh Hashemzadeh boasts an exemplary educational background in biotechnology and medical sciences. He began his academic journey with a Bachelor of Science (B.Sc.) degree, graduating with top honors and consistently ranking first among his peers. Driven by his passion for advanced research, Dr. Hashemzadeh pursued a Master of Science (M.Sc.) degree, where he continued to excel academically and was recognized for his outstanding performance. He then attained his Ph.D. in Nano Biotechnology from Baqiyatallah University of Medical Sciences, a prestigious institution in Iran, where he focused on recombinant protein expression and the application of nanotechnology in medical diagnostics. Following his doctoral studies, Dr. Hashemzadeh undertook postdoctoral research at the Pasteur Institute of Iran, specializing in innovative cell therapy techniques for rheumatoid arthritis. Throughout his education, he has received numerous accolades, including the first prize at the 15th International Congress of Microbiology, underscoring his dedication and excellence in the field. His comprehensive education has provided him with a solid foundation in molecular genetics, genetic engineering, and cutting-edge biotechnological methodologies.

Professional Experience

Dr. Mohammad Sadegh Hashemzadeh is an accomplished Assistant Professor at Baqiyatallah University of Medical Sciences, Tehran, Iran, with a strong background in Medical and Nano Biotechnology. His expertise spans molecular genetics, genetic engineering, and cell culture, focusing on producing recombinant proteins for therapeutic applications. Dr. Hashemzadeh’s research interests include cell therapy for rheumatoid arthritis, recombinant protein production, and viral vector engineering. He has completed a Post-Doc in cell therapy of inflammatory diseases and has been involved in various research projects, including the construction of recombinant viruses and the development of viral-like particles (VLPs) for potential therapeutic use. In addition to his research contributions, Dr. Hashemzadeh is an experienced educator, having taught courses in genetics, immunology, and nanotechnology at both undergraduate and postgraduate levels. His professional achievements are further underscored by his numerous publications in high-impact journals and his recognition through several awards and honors.

Research Interest

Dr. Mohammad Sadegh Hashemzadeh’s research interests primarily focus on the intersection of medical biotechnology and nano-biotechnology. His work spans the development of advanced therapeutic applications, particularly in molecular genetics, genetic engineering, and cell therapy for inflammatory diseases like rheumatoid arthritis. He is deeply engaged in the production of recombinant proteins, utilizing cell culture techniques to develop viral vectors and virus-like particles (VLPs) for potential cancer treatments and vaccine development. His research also includes exploring the role of peptide nucleic acids (PNAs) in detecting and treating diseases caused by biological threat agents. Additionally, Dr. Hashemzadeh investigates the application of oncolytic viruses in cancer therapy and the development of novel diagnostic methods using nanotechnology. His work is aimed at translating cutting-edge biotechnological advancements into practical solutions for complex medical challenges, contributing to the fields of virology, immunology, and therapeutic protein production.

Research Skills

Dr. Mohammad Sadegh Hashemzadeh possesses a diverse and advanced skill set in the field of biotechnology and nanotechnology. His expertise encompasses molecular genetics, genetic engineering, and cell culture, with a focus on producing recombinant proteins for therapeutic applications. His research is distinguished by his proficiency in the development and application of viral vectors and protein-based vaccines, particularly in the context of cell therapy and vaccine production. Dr. Hashemzadeh has extensive experience in the expression, solubilization, and purification of recombinant proteins, utilizing techniques such as real-time PCR and nanotechnology for diagnostic and therapeutic purposes. His work involves the synthesis and characterization of nanomaterials and viral-like particles (VLPs), contributing to advancements in diagnostic methods and biological threat detection. His skills are supported by a robust publication record in international journals, reflecting his significant contributions to the fields of molecular biotechnology and medical research.

Award and Recognition

Dr. Mohammad Sadegh Hashemzadeh has garnered notable recognition for his exceptional contributions to the fields of biotechnology and nanotechnology. His academic journey is marked by distinguished achievements, including being first-ranked among his peers during his MSc and PhD studies, and receiving accolades such as the First Prize at the 15th International Congress of Microbiology in 2014. His innovative research has been published in prestigious journals, underscoring his influence in the scientific community. Dr. Hashemzadeh’s work on the development of recombinant proteins and viral protein vaccines, as well as his significant contributions to the understanding of biological threat agents through nanotechnology, has earned him commendation. His dedication to advancing medical biotechnology and his role in pioneering research in cell therapy and genetic engineering reflect his outstanding contributions and make him a deserving candidate for further recognition and awards.

Conclusion

Dr. Mohammad Sadegh Hashemzadeh is a highly qualified candidate for the Research for Best Researcher Award, with a solid academic foundation, a track record of excellence in research, and contributions to medical biotechnology and nanotechnology. His continuous pursuit of innovative research and dedication to teaching underscore his suitability for this award. However, to further strengthen his candidacy, increased focus on collaborative research, securing research funding, and enhancing the practical application of his work could be beneficial.

Publications Top Notes

  1. Zinc Oxide Nanoparticles and Cancer Chemotherapy: Helpful Tools for Enhancing Chemo-sensitivity and Reducing Side Effects?
    • Authors: Vaghari-Tabari, M., Jafari-Gharabaghlou, D., Mohammadi, M., Hashemzadeh, M.S.
    • Journal: Biological Trace Element Research
    • Year: 2024
    • Volume and Issue: 202(5), pp. 1878–1900
    • Citations: 3
  2. Therapeutic Effects of IL-1RA, M2 Cells, and Their Synergistic Impact on a Mouse Model of Rheumatoid Arthritis
    • Authors: Hashemzadeh, M.S., Ghaleh, H.E.G., Mohammadi, M., Rezaei, E., Alishiri, G.
    • Journal: Advanced Pharmaceutical Bulletin
    • Year: 2024
    • Volume and Issue: 14(2), pp. 483–495
    • Citations: 0
  3. Correction: Biosynthesis of a VLP-type nanocarrier specific to cancer cells using the BEVS expression system for targeted drug delivery (Journal of Genetic Engineering and Biotechnology, (2023), 21, 1, (20), 10.1186/s43141-023-00479-9)
    • Authors: Hashemzadeh, M.S., Gharari, N.
    • Journal: Journal of Genetic Engineering and Biotechnology
    • Year: 2023
    • Volume and Issue: 21(1), 40
    • Citations: 1
  4. Biosynthesis of a VLP-type nanocarrier specific to cancer cells using the BEVS expression system for targeted drug delivery
    • Authors: Hashemzadeh, M.S., Gharari, N.
    • Journal: Journal of Genetic Engineering and Biotechnology
    • Year: 2023
    • Volume and Issue: 21(1), 20
    • Citations: 3
  5. Utilization of Freeze-Thawing Method for High-level Expression of Functional Human Epidermal Growth Factor (hEGF)
    • Authors: Mohammadi, M., Ghanbari, S., Emamgholi, A., Hashemzadeh, M.S.
    • Journal: International Journal of Peptide Research and Therapeutics
    • Year: 2023
    • Volume and Issue: 29(3), 38
    • Citations: 1
  6. Utilization of SUMO Tag and Freeze-thawing Method for a High-level Expression and Solubilization of Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) Protein in E. coli
    • Authors: Mohammadi, M., Taheri, R.A., Bemani, P., Farnoosh, G., Amini, R.
    • Journal: Protein and Peptide Letters
    • Year: 2022
    • Volume and Issue: 29(7), pp. 605–610
    • Citations: 4
  7. Evaluation of the acute and 28-day sub-acute intravenous toxicity of α-l-guluronic acid (ALG; G2013) in mice
    • Authors: Mahdian-Shakib, A., Hashemzadeh, M.S., Anissian, A., Oraei, M., Mirshafiey, A.
    • Journal: Drug and Chemical Toxicology
    • Year: 2022
    • Volume and Issue: 45(1), pp. 151–160
    • Citations: 6
  8. The role of bacterial superantigens in the immune response: From biology to cancer treatment
    • Authors: Hashemzadeh, M.S., Tapeh, B.E.G., Mirhosseini, S.A.
    • Journal: Current Cancer Therapy Reviews
    • Year: 2021
    • Volume and Issue: 17(1), pp. 21–34
    • Citations: 1
  9. Expression, solubilization, refolding and final purification of recombinant proteins as expressed in the form of “classical inclusion bodies” in e. coli
    • Authors: Hashemzadeh, M.S., Mohammadi, M., Ghaleh, H.E.G., Choopani, A., Panda, A.K.
    • Journal: Protein and Peptide Letters
    • Year: 2021
    • Volume and Issue: 28(2), pp. 2–10
    • Citations: 16
  10. Detection of West Nile virus by real-time PCR in crows in northern provinces of Iran
    • Authors: Sharti, M., Amouakbari, M.J., Pourjabari, K., Omidifar, A., Dorostkar, R.
    • Journal: Journal of Vector Borne Diseases
    • Year: 2020
    • Volume and Issue: 57(1), pp. 37–39
    • Citations: 2